Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Malaria Vaccines
Research conducted at University of Edinburgh has provided new information about malaria vaccines
December 31st, 2008
Data detailed in 'Mixed allele malaria vaccines: host protection and within-host selection' have been presented. According to recent research published in the journal Vaccine, "Malaria parasites are frequently polymorphic at the antigenic targets of many candidate vaccines, presumably as a consequence of selection pressure from protective immune responses. Conventional wisdom is therefore that vaccines directed against a single variant could select for non-target variants, rendering the vaccine useless." "Many people have argued that a solution is to develop vaccines containing the products of more than one variant of the target. However, we are unaware of any...
Source: Vaccine Weekly (2008-12-31)
|
